General - Additional Information (Details) (USD $)
In Thousands, except Share data, unless otherwise specified |
0 Months Ended | 9 Months Ended | 0 Months Ended | |||||
---|---|---|---|---|---|---|---|---|
Sep. 30, 2014
|
Dec. 31, 2013
|
Feb. 20, 2014
Inogen, Inc.
|
Feb. 20, 2014
Stockholders
|
Feb. 20, 2014
Initial Public Offering (IPO)
|
Sep. 30, 2014
Initial Public Offering (IPO)
|
Feb. 20, 2014
Initial Public Offering (IPO)
Inogen, Inc.
|
Feb. 20, 2014
Initial Public Offering (IPO)
Stockholders
|
|
General Disclosures [Line Items] | ||||||||
Number of shares sold | 3,529,411 | 882,352 | 4,511,313 | 3,529,411 | 981,902 | |||
Common stock, par value | $ 16.00 | |||||||
Amount after underwriters discount and other associated expenses | $ 49,668 | |||||||
Common stock, shares outstanding | 18,436,802 | 280,974 | 18,436,802 |
X | ||||||||||
- Definition
Amount after underwriters discount and other associated expense. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. No definition available.
|
X | ||||||||||
- Definition
Amount per share or per unit of equity securities issued by non-development stage entity. No definition available.
|